Now showing items 1-5 of 5

    • Afrezza: Fast-Acting Inhaled Insulin 

      Aschenbrenner, Diane S. (American Journal of Nursing, 2014-10)
      Afrezza (insulin human) is a newly approved fast-acting inhaled insulin. It can be used in treating type 1 diabetes when added to a long-acting insulin; in studies, patients with type 2 diabetes used it in combination with ...
    • Asthma Medication Receives New Warning 

      Aschenbrenner, Diane S. (American Journal of Nursing, 2015-01)
      The labeling of omalizumab (Xolair), a drug used to treat allergic asthma, now carries a warning that its use may slightly increase the risk of cardiovascular complications. The drug may also pose an increased risk of ...
    • DRUG Watch 

      Aschenbrenner, Diane S. (American Journal of Nursing, 2017-06)
      The article reports on drugs that received approval from the U.S. Food and Drug Administration. It notes on the approval given to deflazacort (Emflaza) as treatment for Duchenne muscular dystrophy, the most common type of ...
    • IV Docetaxel Can Induce Alcohol Intoxication 

      Aschenbrenner, Diane S. (American Journal of Nursing, 2014-10)
      Docetaxel, a commonly used IV chemotherapeutic agent, can produce alcohol intoxication. Alcohol is used to dissolve the active ingredients so that the drug can be given intravenously. The amount of alcohol in each dose ...
    • New Treatment for Opioid-Induced Constipation 

      Aschenbrenner, Diane S. (American Journal of Nursing, 2015-01)
      The opioid antagonist naloxegol (Movantik) is now approved to treat opioid-induced constipation in adults with chronic noncancer pain. The most common adverse effects are abdominal pain, diarrhea, nausea, flatulence, ...